Zelira Therapeutics Ltd (ZLD.AX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [ASX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
(Values in thousands)
| 06-2025 | 06-2024 | 06-2023 | 06-2022 | 06-2021 | |
| Sales | 1 | 95 | 301 | 1,541 | 433 |
| Cost of Goods | 9 | 85 | 363 | 939 | 228 |
| Gross Profit | -8 | 10 | -61 | 602 | 204 |
| Operating Expenses | 3,801 | 5,949 | 7,202 | 14,247 | 10,196 |
| Operating Income | -3,809 | -5,938 | -7,263 | -13,645 | -9,991 |
| Interest Expense | 407 | 739 | 77 | 54 | 43 |
| Other Income | 367 | -30,062 | 1,071 | 1,286 | 1,485 |
| Pre-tax Income | -3,850 | -36,740 | -6,269 | -12,414 | -8,549 |
| Net Income Continuous | -3,850 | -36,740 | -6,269 | -12,414 | -8,549 |
| Minority Interests | 222 | 171 | 696 | 468 | N/A |
| Net Income | $-3,628 | $-36,569 | $-5,573 | $-11,945 | $-8,549 |
| EPS Basic Total Ops | -0.32 | -3.22 | -0.55 | -1.54 | -1.28 |
| EPS Basic Continuous Ops | -0.32 | -3.22 | -0.55 | -1.54 | -1.28 |
| EPS Diluted Total Ops | -0.32 | -3.22 | -0.55 | -1.54 | -1.28 |
| EPS Diluted Continuous Ops | -0.32 | -3.22 | -0.55 | -1.54 | -1.28 |
| EBITDA(a) | $-3,172 | $-35,521 | $-5,647 | $-11,771 | $-8,032 |